Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhu, J.
Right arrow Articles by Epstein, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, J.
Right arrow Articles by Epstein, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 6, 785-790, June 2001
© 2001 Japanese Society for Immunology

Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response

Jianhui Zhu, Gene M. Shearer,1, Francesco M. Marincola,1, James E. Norman,2, David Rott, Jian-Ping Zou,1 and Stephen E. Epstein

Cardiovascular Research Institute, Washington Hospital Center, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010, USA
1 National Cancer Institute, and
2 Division of Epidemiology and Clinical Applications, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Correspondence to: S. E. Epstein

Previous studies have documented discordant cellular and humoral immune responses to subjects exposed to HIV-1, and that the nature of such responses may determine susceptibility and resistance to disease. We determined whether there is a spectrum of cellular versus humoral immunodominant responses to cytomegalovirus (CMV) infection. Blood samples from 50 healthy blood donors were tested for anti-CMV IgG antibodies and for proliferative responses of peripheral blood mononuclear cells (PBMC) to CMV antigens. Four patterns of immune responses to CMV were found: no detectable response (30%, Ab/Tc), anti-CMV IgG only (28%, Ab+/Tc), both anti-CMV IgG and T lymphocyte proliferation to CMV antigens (18%, Ab+/Tc+), and, interestingly, T lymphocyte proliferation to CMV only (24%, Ab/Tc+). To determine whether these immunodominant phenotypes correlate with the ability of PBMC to secrete IL-2 and IFN-{gamma} in response to CMV antigens, we found that a greater percentage of individuals with a T cell proliferative response to CMV antigens (Ab/Tc+ and Ab+/Tc+) responded with increased IL-2 (P = 0.001) and IFN-{gamma} levels (P = 0.002), compared to those without a proliferative response (Ab/Tc and Ab+/Tc). Our data therefore demonstrate that different individuals exhibit different immunodominant patterns of response to CMV. In particular, some individuals who are exposed to CMV fail to develop an antibody response but do develop cellular immunity. Whether these different patterns predict susceptibility or resistance to CMV-induced disease remains to be determined.

Keywords: antibody, cellular proliferation, cytokines, infectious immunity, virus

Transmitting editor: L. Moretta


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. Sester, U. Sester, B. C. Gartner, M. Girndt, A. Meyerhans, and H. Kohler
Dominance of Virus-Specific CD8 T Cells in Human Primary Cytomegalovirus Infection
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2577 - 2584.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.